Antimicrobial activity of Xanthium cavanillesii extracts

Pharmaceutical Biology

Volumn 45, Issue 3, 2007, Pages 251-254

  Cerdeiras, M P ^a   Albores S ^a   Etcheverry, S ^a   Lucian V ^a   Soubes, M ^a   Vazquez A ^a  

^a UNIVERSIDAD DE LA REPÚBLICA   (Uruguay)

Author keywords

Abrojo; Antibacterial activity; Candida; Mycobacterium

Indexed keywords

ANTIINFECTIVE AGENT; PLANT EXTRACT; UNCLASSIFIED DRUG; XANTHIUM CAVANILLESII EXTRACT;

AGAR GEL DIFFUSION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIMICROBIAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CONTROLLED STUDY; MEDICINAL PLANT; MICROORGANISM; MOUSE; MYCOBACTERIUM SMEGMATIS; NONHUMAN; RAT; XANTHIUM CAVANILLESII;

ASTERACEAE; CANDIDA; CANDIDA ALBICANS; MYCOBACTERIUM; MYCOBACTERIUM SMEGMATIS; OPUNTIA TUNICATA; XANTHIUM STRUMARIUM CANADENSE;

EID: 34247637134     PISSN: 13880209     EISSN: 17445116     Source Type: Journal    
DOI: 10.1080/13880200701214839     Document Type: Article

References (20)

1. Ahmed AA, Jakupovic J, Bohlman F, Ahmed AM (1990): Sesquiterpene lactones from Xanthium pungens. Phytochemistry 29: 2211-2215.
2. Anonymous (2004): The World Health Report 2004: Changing History. Geneva, WHO.
3. Barry AL, Thomsberry JC (1985): In: Lenette EH, ed., Manual of Clinical Microbiology. Washington, DC, American Society of Microbiology.
4. Bohlman F, Zdero C (1981): An isomer of xanthanol from Xanthium orientale. Phytochemistry 20: 1891-1893.
5. Cassady JM, Baird WM, Chang CJ (1990): Natural products as a source of potential cancer chemotherapeutic and chemopreventive agents. J Nat Prod 53: 23-41.
6. Clark AM (1996): Natural products as a resource of new drugs. Pharm Res 13: 61-70.
7. Cos P, Vlietinck AJ, Vander Berghe D, Maes L (2006): Anti-infective potential of natural products: How to develop a stronger in vitro proof-of-concept. J Ethnopharmacol 106: 290-302.
8. Cowan MM (1999): Plant products as antimicrobial agents. Clin Microbiol Rev 12: 564-581.
9. de Riscala EC, Fortuna MA, Catalan CAN, Diaz JG, Herz W (1994): Xanthanolides and a bis-norxanthanolide from Xanthium cavanillesii. Phytochemistry 35: 1588-1589.
10. Elloff JN (1998): Which extract should be used for the screening and isolation of antimicrobial components from plants? J Ethnopharmacol 60: 1-8.
11. Ginesta-Peris E, García-Breijo FJ, Primo Yútera E (1994): Antimicrobial activity of xanthatin from Xanthium spinosum L. Lett Appl Microbiol 18: 206-208.
12. Hsu FL, Chen Y, Cheng J (2000): Caffeic acid as active principle of fruits Xanthium strumarium to lower plasma glucose in diabetics rats. Planta Med 66: 228-230.
13. Institute of Laboratory Animal Resources (1996): Guide for the Care and Use of Laboratory Animals. Washington, DC, National Academy Press.
14. Lewis WH, Elvin-Lewis MP (1995): Medicinal plants as sources of new therapeutics. Ann Missouri Botanical Garden 82: 16-24.
15. Lombardo A (1983): Flora Montevidensis. Montevideo, IMM.
16. Mangel SM, Sangwan NK, Dhindsa K (1992): Xanthanolides from Xanthium strumarium. Phytochemistry 32: 206-207.
17. Morton DB, Griffiths PHM (1985): Guidelines on the recognition of pain, distress and discomfort in experimental animals and an hypothesis for assessment. Vet Record 116: 431-436.
18. OECD (2001): Guideline for Testing of Chemicals - Acute Oral Toxicity - Up and Down Procedure. Organization for Economic Co-operation and Development. Available at http://www.epa.gov/oppfead1/harmonization/docs/ E425guideline.pdf.
19. Omar AA, Ghazy NA, Metwally AM, Ziesche J, Bohlman F (1984): Xanthanolides from Xanthium spinosum. Phytochemistry 23: 915-916.
20. Tsankova ET, Trendafilova AB, Kujumgiev AI, Galabov AS, Robeva PR (1994): Xanthanolides of Xanthium italicum Moretti and their biological activity. Z Naturforschung C 49: 154-159.